Discover the advancements in cancer treatment with Dr. Jaime L. Schneider as she delves into the era of precision oncology. Learn about the transition from traditional treatments to targeted therapies and immunotherapies, and understand the significance of genomic alterations in cancer. This video explores the critical role of biomarker testing in non-small cell lung cancer and other cancers, highlighting the impact of molecular profiling on patient outcomes.

Key Topics:
• Evolution of cancer treatment paradigms
• Importance of genomic alterations and targeted therapies
• Biomarker testing in lung and other cancers

Access a downloadable transcript of this webinar at https://targeted-therapies-lung-cancer.ime.springerhealthcare.com/#chapter1

This episode is 1 of 4, and is part is part of an ACCME- and EACCME-accredited, Independent Medical Education program entitled, Biomarker-Positive Disease: A Personalized Approach to Selecting Targeted Therapies in Lung Cancer and Beyond.

To learn more about the full program or to CLAIM YOUR CREDITS, visit https://targeted-therapies-lung-cancer.ime.springerhealthcare.com/
---
This activity is supported by independent educational grants from Roche and Illumina.